182 related articles for article (PubMed ID: 10404957)
61. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
62. A novel therapeutic strategy against vascular disorders with chymase inhibitor.
Takai S; Miyazaki M
Curr Vasc Pharmacol; 2003 Jun; 1(2):217-24. PubMed ID: 15320845
[TBL] [Abstract][Full Text] [Related]
63. Tissue angiotensin II system in the human heart.
Urata H; Hoffmann S; Ganten D
Eur Heart J; 1994 Dec; 15 Suppl D():68-78. PubMed ID: 7713117
[TBL] [Abstract][Full Text] [Related]
64. Cloning of the gene and cDNA for hamster chymase 2, and expression of chymase 1, chymase 2 and angiotensin-converting enzyme in the terminal stage of cardiomyopathic hearts.
Shiota N; Fukamizu A; Okunishi H; Takai S; Murakami K; Miyazaki M
Biochem J; 1998 Jul; 333 ( Pt 2)(Pt 2):417-24. PubMed ID: 9657983
[TBL] [Abstract][Full Text] [Related]
65. Chymase-like angiotensin II-generating activity in end-stage human autosomal dominant polycystic kidney disease.
McPherson EA; Luo Z; Brown RA; LeBard LS; Corless CC; Speth RC; Bagby SP
J Am Soc Nephrol; 2004 Feb; 15(2):493-500. PubMed ID: 14747398
[TBL] [Abstract][Full Text] [Related]
66. The expression of angiotensin-I converting enzyme in human atherosclerotic plaques is not related to the deletion/insertion polymorphism but to the risk of restenosis after coronary interventions.
Haberbosch W; Bohle RM; Franke FE; Danilov S; Alhenc-Gelas F; Braun-Dullaeus R; Hölschermann H; Waas W; Tillmanns H; Gardemann A
Atherosclerosis; 1997 Apr; 130(1-2):203-13. PubMed ID: 9126666
[TBL] [Abstract][Full Text] [Related]
67. Angiotensin II formation in the human heart: an ACE or non-ACE-mediated pathway?
Kokkonen JO; Saarinen J; Kovanen PT
Ann Med; 1998 Aug; 30 Suppl 1():9-13. PubMed ID: 9800878
[TBL] [Abstract][Full Text] [Related]
68. Tissue-specific expression of renin-angiotensin system components in IgA nephropathy.
Miyake-Ogawa C; Miyazaki M; Abe K; Harada T; Ozono Y; Sakai H; Koji T; Kohno S
Am J Nephrol; 2005; 25(1):1-12. PubMed ID: 15644622
[TBL] [Abstract][Full Text] [Related]
69. Localization of heparin-binding epidermal growth factor-like growth factor in human coronary arteries. Possible roles of HB-EGF in the formation of coronary atherosclerosis.
Nakata A; Miyagawa J; Yamashita S; Nishida M; Tamura R; Yamamori K; Nakamura T; Nozaki S; Kameda-Takemura K; Kawata S; Taniguchi N; Higashiyama S; Matsuzawa Y
Circulation; 1996 Dec; 94(11):2778-86. PubMed ID: 8941102
[TBL] [Abstract][Full Text] [Related]
70. Upregulation of cathepsin C expression contributes to endothelial chymase activation in preeclampsia.
Gu Y; Lewis DF; Alexander JS; Wang Y
Hypertens Res; 2017 Dec; 40(12):976-981. PubMed ID: 28878298
[TBL] [Abstract][Full Text] [Related]
71. ACE-dependent and chymase-dependent angiotensin II generation in normal and glucose-stimulated human mesangial cells.
Cristovam PC; Arnoni CP; de Andrade MC; Casarini DE; Pereira LG; Schor N; Boim MA
Exp Biol Med (Maywood); 2008 Aug; 233(8):1035-43. PubMed ID: 18480420
[TBL] [Abstract][Full Text] [Related]
72. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.
Doggrell SA; Wanstall JC
Cardiovasc Res; 2004 Mar; 61(4):653-62. PubMed ID: 14985062
[TBL] [Abstract][Full Text] [Related]
73. Effect of Angiotensin II Type 1 receptor blocker on cardiac angiotensin-converting enzyme and chymase-like activities, and cardiac fibrosis in cardiomyopathic hamsters.
Shimizu M; Tanaka R; Uchida M; Orito K; Shimamura S; Yamane Y
J Vet Med Sci; 2006 Mar; 68(3):227-33. PubMed ID: 16598165
[TBL] [Abstract][Full Text] [Related]
74. Functional and biochemical analysis of angiotensin II-forming pathways in the human heart.
Wolny A; Clozel JP; Rein J; Mory P; Vogt P; Turino M; Kiowski W; Fischli W
Circ Res; 1997 Feb; 80(2):219-27. PubMed ID: 9012744
[TBL] [Abstract][Full Text] [Related]
75. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.
Koka V; Wang W; Huang XR; Kim-Mitsuyama S; Truong LD; Lan HY
Circulation; 2006 Mar; 113(10):1353-60. PubMed ID: 16520412
[TBL] [Abstract][Full Text] [Related]
76. Mast cell chymase expression in Helicobacter pylori-associated gastritis.
Matsuo T; Ikura Y; Ohsawa M; Ogami M; Kayo S; Yoshimi N; Hai E; Naruko T; Ohishi M; Higuchi K; Arakawa T; Ueda M
Histopathology; 2003 Dec; 43(6):538-49. PubMed ID: 14636254
[TBL] [Abstract][Full Text] [Related]
77. Transgenic study of the function of chymase in heart remodeling.
Chen LY; Li P; He Q; Jiang LQ; Cui CJ; Xu L; Liu LS
J Hypertens; 2002 Oct; 20(10):2047-55. PubMed ID: 12359984
[TBL] [Abstract][Full Text] [Related]
78. Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: their role in the formation of stable and unstable carotid atherosclerotic plaques.
Morioka M; Hamada J; Hashiguchi A; Hasegawa Y; Todaka T; Yano S; Kai Y; Miura M; Fujioka S; Ushio Y
Surg Neurol; 2004 Oct; 62(4):292-301; discussion 301-3. PubMed ID: 15451269
[TBL] [Abstract][Full Text] [Related]
79. Expression of angiotensin II and interleukin 6 in human coronary atherosclerotic plaques: potential implications for inflammation and plaque instability.
Schieffer B; Schieffer E; Hilfiker-Kleiner D; Hilfiker A; Kovanen PT; Kaartinen M; Nussberger J; Harringer W; Drexler H
Circulation; 2000 Mar; 101(12):1372-8. PubMed ID: 10736279
[TBL] [Abstract][Full Text] [Related]
80. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum.
Iwamoto Y; Song K; Takai S; Yamada M; Jin D; Sakaguchi M; Ueda H; Katsuoka Y; Miyazaki M
J Pharmacol Exp Ther; 2001 Jul; 298(1):43-8. PubMed ID: 11408523
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
